|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/7068 | (2013.01) | ||
| A61K 38/07 | (2013.01) | ||
| C07D 471/04 | (2013.01) |
| (11) | Number of the document | 4141005 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22176014.3 |
| Date of filing the European patent application | 2018-09-07 | |
| (97) | Date of publication of the European application | 2023-03-01 |
| (45) | Date of publication and mention of the grant of the patent | 2024-04-03 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201762556223 P | 2017-09-08 | US |
| (72) |
LANMAN, Brian Alan , US
BOOKER, Shon , US
GOODMAN, Clifford , US
REED, Anthony B. , US
LOW, Jonathan D. , US
WANG, Hui-Ling , US
CHEN, Ning , US
MINATTI, Ana Elena , US
WURZ, Ryan , US
CEE, Victor J. , US
|
| (73) |
Amgen Inc. ,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | INHIBITORS OF KRAS G12C AND METHODS OF USING THE SAME |
| INHIBITORS OF KRAS G12C AND METHODS OF USING THE SAME |